These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Oncogenes in human hematopoietic neoplasia]. Larsen C Pathol Biol (Paris); 1992 Nov; 39(9):867-8. PubMed ID: 1538913 [No Abstract] [Full Text] [Related]
3. Tumor suppressor genes in normal and malignant hematopoiesis. Krug U; Ganser A; Koeffler HP Oncogene; 2002 May; 21(21):3475-95. PubMed ID: 12032783 [TBL] [Abstract][Full Text] [Related]
4. Truncated TSG101 transcripts in human leukemia and lymphoma cell lines. Hosokawa Y; Nagai E; Seto M J Cancer Res Clin Oncol; 2000 Feb; 126(2):79-84. PubMed ID: 10664246 [TBL] [Abstract][Full Text] [Related]
5. Two decades of cancer genetics: from specificity to pleiotropic networks. Grisendi S; Pandolfi PP Cold Spring Harb Symp Quant Biol; 2005; 70():83-91. PubMed ID: 16869741 [TBL] [Abstract][Full Text] [Related]
6. p53 alterations in human leukemia-lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization? Drexler HG; Fombonne S; Matsuo Y; Hu ZB; Hamaguchi H; Uphoff CC Leukemia; 2000 Jan; 14(1):198-206. PubMed ID: 10637496 [TBL] [Abstract][Full Text] [Related]
8. [The correlation between alterations of cell cycle-regulating, tumor-suppressor genes and the clinical prognosis in adult ALL patients]. Hangaishi A; Ogawa S Rinsho Ketsueki; 1997 May; 38(5):401-5. PubMed ID: 9194384 [No Abstract] [Full Text] [Related]
9. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698 [TBL] [Abstract][Full Text] [Related]
10. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Brimmell M; Mendiola R; Mangion J; Packham G Oncogene; 1998 Apr; 16(14):1803-12. PubMed ID: 9583678 [TBL] [Abstract][Full Text] [Related]
11. p53 mutation heterogeneity in cancer. Soussi T; Lozano G Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939 [TBL] [Abstract][Full Text] [Related]
12. hBUB1 defects in leukemia and lymphoma cells. Ru HY; Chen RL; Lu WC; Chen JH Oncogene; 2002 Jul; 21(30):4673-9. PubMed ID: 12096343 [TBL] [Abstract][Full Text] [Related]
13. [Mutations of several tumor suppressor genes in primary retinoblastoma]. Huang Q; Tao Y; Yandell DW Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785 [TBL] [Abstract][Full Text] [Related]
14. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Liu G; Parant JM; Lang G; Chau P; Chavez-Reyes A; El-Naggar AK; Multani A; Chang S; Lozano G Nat Genet; 2004 Jan; 36(1):63-8. PubMed ID: 14702042 [TBL] [Abstract][Full Text] [Related]
15. Oncogenic changes in murine lymphoid tumors induced by in utero exposure to ionizing radiation. Lumniczky K; Antal S; Unger E; Hidvégi EJ; Sáfrány G Radiat Oncol Investig; 1997; 5(3):158-62. PubMed ID: 9303076 [TBL] [Abstract][Full Text] [Related]
17. [The cell cycle and the tumor suppressor genes]. Kobayashi H Rinsho Byori; 1996 Jan; 44(1):3-11. PubMed ID: 8691637 [TBL] [Abstract][Full Text] [Related]
18. [Cell cycle, tumor suppressor genes and lung cancers]. Bréchot JM Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of human endothelial cell proliferation by Gami--Jeonggi--San (Jiawei--Zhenqi--San) is accompanied by transcriptional up-regulation of p53 and Waf1 tumor suppressor genes. Moon SK; Jin HS; Ko CN; Kim YS; Bae HS; Lee KS; Cho KH J Ethnopharmacol; 2005 Aug; 100(1-2):187-92. PubMed ID: 15941636 [TBL] [Abstract][Full Text] [Related]
20. V(D)J recombination is not required for the development of lymphoma in p53-deficient mice. Nacht M; Jacks T Cell Growth Differ; 1998 Feb; 9(2):131-8. PubMed ID: 9486849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]